179 related articles for article (PubMed ID: 24076374)
1. Musashi2 modulates K562 leukemic cell proliferation and apoptosis involving the MAPK pathway.
Zhang H; Tan S; Wang J; Chen S; Quan J; Xian J; Zhang Ss; He J; Zhang L
Exp Cell Res; 2014 Jan; 320(1):119-27. PubMed ID: 24076374
[TBL] [Abstract][Full Text] [Related]
2. Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin.
Han Y; Ye A; Zhang Y; Cai Z; Wang W; Sun L; Jiang S; Wu J; Yu K; Zhang S
PLoS One; 2015; 10(8):e0136484. PubMed ID: 26308531
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome-wide analysis uncovers the targets of the RNA-binding protein MSI2 and effects of MSI2's RNA-binding activity on IL-6 signaling.
Duggimpudi S; Kloetgen A; Maney SK; Münch PC; Hezaveh K; Shaykhalishahi H; Hoyer W; McHardy AC; Lang PA; Borkhardt A; Hoell JI
J Biol Chem; 2018 Oct; 293(40):15359-15369. PubMed ID: 30126842
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
5. Betuletol 3-methyl ether induces G(2)-M phase arrest and activates the sphingomyelin and MAPK pathways in human leukemia cells.
Rubio S; Quintana J; Eiroa JL; Triana J; Estévez F
Mol Carcinog; 2010 Jan; 49(1):32-43. PubMed ID: 19676104
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells.
Ding SZ; Smith MF; Goldberg JB
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e67-78. PubMed ID: 18702686
[TBL] [Abstract][Full Text] [Related]
7. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
[TBL] [Abstract][Full Text] [Related]
8. Key regulators in bee venom-induced apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells through downregulation of ERK and Akt.
Moon DO; Park SY; Heo MS; Kim KC; Park C; Ko WS; Choi YH; Kim GY
Int Immunopharmacol; 2006 Dec; 6(12):1796-807. PubMed ID: 17052670
[TBL] [Abstract][Full Text] [Related]
9. Dynamic transcriptomes of human myeloid leukemia cells.
Wang H; Hu H; Zhang Q; Yang Y; Li Y; Hu Y; Ruan X; Yang Y; Zhang Z; Shu C; Yan J; Wakeland EK; Li Q; Hu S; Fang X
Genomics; 2013 Oct; 102(4):250-6. PubMed ID: 23806289
[TBL] [Abstract][Full Text] [Related]
10. Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells.
Kohmura K; Miyakawa Y; Kawai Y; Ikeda Y; Kizaki M
J Cell Physiol; 2004 Mar; 198(3):370-6. PubMed ID: 14755542
[TBL] [Abstract][Full Text] [Related]
11. Paris saponin VII induces cell cycle arrest and apoptosis by regulating Akt/MAPK pathway and inhibition of P-glycoprotein in K562/ADR cells.
Yan T; Hu G; Wang A; Sun X; Yu X; Jia J
Phytother Res; 2018 May; 32(5):898-907. PubMed ID: 29377384
[TBL] [Abstract][Full Text] [Related]
12. PKC pathway and ERK/MAPK pathway are required for induction of cyclin D1 and p21Waf1 during 12-o-tetradecanoylphorbol 13-acetate-induced differentiation of myeloleukemia cells.
Matsumoto E; Hatanaka M; Bohgaki M; Maeda S
Kobe J Med Sci; 2006; 52(6):181-94. PubMed ID: 17329956
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia.
Thol F; Winschel C; Sonntag AK; Damm F; Wagner K; Chaturvedi A; Göhring G; Schlegelberger B; Lübbert M; Fiedler W; Kirchner H; Krauter J; Ganser A; Heuser M
Ann Hematol; 2013 Mar; 92(3):315-23. PubMed ID: 23233047
[TBL] [Abstract][Full Text] [Related]
14. Musashi 2 in hematopoiesis.
de Andrés-Aguayo L; Varas F; Graf T
Curr Opin Hematol; 2012 Jul; 19(4):268-72. PubMed ID: 22517588
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.
Nimmanapalli R; O'Bryan E; Huang M; Bali P; Burnette PK; Loughran T; Tepperberg J; Jove R; Bhalla K
Cancer Res; 2002 Oct; 62(20):5761-9. PubMed ID: 12384536
[TBL] [Abstract][Full Text] [Related]
16. Anti-leukemic effect of 2-pyrone derivatives via MAPK and PI3 kinase pathways.
Yoon JS; Won YW; Kim SJ; Oh SJ; Kim ES; Kim BK; Cho CG; Choi JH; Park BB; Lee MH; Lee YY
Invest New Drugs; 2012 Dec; 30(6):2284-93. PubMed ID: 22526834
[TBL] [Abstract][Full Text] [Related]
17. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
[TBL] [Abstract][Full Text] [Related]
18. [Effect of WT1 antisense oligonucleotide on proliferation and apoptosis of human leukemia cells].
Wu X; Wang Y; Pei X
Zhonghua Xue Ye Xue Za Zhi; 1999 Dec; 20(12):631-3. PubMed ID: 11721364
[TBL] [Abstract][Full Text] [Related]
19. Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade.
Mandal C; Dutta A; Mallick A; Chandra S; Misra L; Sangwan RS; Mandal C
Apoptosis; 2008 Dec; 13(12):1450-64. PubMed ID: 18987975
[TBL] [Abstract][Full Text] [Related]
20. Bcl-xL is a dominant antiapoptotic protein that inhibits homoharringtonine-induced apoptosis in leukemia cells.
Yin S; Wang R; Zhou F; Zhang H; Jing Y
Mol Pharmacol; 2011 Jun; 79(6):1072-83. PubMed ID: 21415308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]